Earth Science Tech, Inc. (ETST) Sets Testing Dates for Cannabinoid-Based Products
Quebec grant will help develop its cannabinoid products; ETST testing will commence in 4Q2018 on formula patents aimed at preventing cancer and other diseases ETST will apply for trademark, finalize packaging for debut of medical device designed to diminish sexually transmitted infections; women will be target audience for this product Company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol Earth Science Tech, Inc. (OTC: ETST) has established testing dates for three of its cannabinoid-based (CBD) products. Funded by a grant from Quebec, ETST is now prototyping three CBD…